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ndergoing Percutaneous Coronary Intervention
abor Gyenes, MD, PHD,* Fiona M. Shrive, BSC,† Michelle M. Graham, MD, FRCP(C),*
illiam A. Ghali, MD, FRCP(C),† Merrill L. Knudtson, MD, FCRP(C),†
or the APPROACH Investigators
dmonton and Calgary, Alberta, Canada
OBJECTIVES The purpose of this research was to study the association between nonsignificant (50%) left
main coronary artery disease (LMCAD) and short- and long-term survival in patients
undergoing percutaneous coronary intervention (PCI).
BACKGROUND The prognostic importance of nonsignificant LMCAD is unknown; however, the co-
existence of nonsignificant LMCAD may influence revascularization decisions.
METHODS We analyzed mortality and repeat catheterization rates of 11,855 patients in a prospective
cardiac registry database who underwent single-vessel or multivessel PCI from January 1996
through December 2001. Of this cohort, 11.7% (n  1,385) had nonsignificant (50%)
LMCAD. Outcomes were compared with those without LMCAD. A secondary analysis was
performed on a larger cohort of 34,586 patients undergoing cardiac catheterization,
irrespective of mode of revascularization therapy.
RESULTS Patients with nonsignificant LMCAD had more co-morbidities, and a significantly higher
crude mortality rate at 1 year compared with those without LMCAD (4.4% vs. 3.4%; p 
0.05). The 7-year crude mortality hazard ratio (HR) of PCI patients with 50% LMCAD
versus those with no LMCAD was 1.18 (95% confidence interval [CI] 0.94 to 1.46). After
risk adjustment for differences in baseline clinical profile, however, the HR decreased to 0.98
(95% CI 0.79 to 1.23). Repeat catheterization rates at 1 year did not differ between groups.
The secondary analysis in all patients with nonsignificant LMCAD showed an adjusted HR
of 1.03 (95% CI 0.94 to 1.14).
CONCLUSIONS Patients undergoing single-vessel or multivessel PCI who have 50% LMCAD have a
nonsignificantly increased 18% relative risk for mortality compared with those without
detectable LMCAD that appears to be related to these patients’ higher incidence of
co-morbidities rather than the left main stenosis itself. (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.067276–80) © 2006 by the American College of Cardiology Foundation
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ct is widely accepted that significant (50%) left main
oronary artery disease (LMCAD) is associated with an
ncreased cardiac mortality. Previous studies have found
oronary artery bypass grafting (CABG) to provide superior
ong-term outcomes than medical management in these
atients (1–4). Although repeatedly challenged by interven-
ional cardiologists, percutaneous coronary intervention
PCI) has traditionally been regarded as a relatively high-
isk revascularization option for significant LMCAD.
herefore, for the majority of patients, CABG is currently
onsidered the revascularization strategy of choice.
The prognostic importance of nonsignificant (50%)
MCAD, however, is less clear. Despite the lack of
upportive scientific evidence, the co-existence of nonsig-
ificant LMCAD with disease of other coronary arteries
ay influence decisions for revascularization options. Some
From the *University of Alberta, Edmonton, Alberta, Canada; and the †University
f Calgary, Calgary, Alberta, Canada. APPROACH was funded in 1995 by the
eston Foundation, with ongoing support from Merck Frosst Canada Inc., Mon-
anto Canada Inc., Searle, Eli Lilly Canada Inc., Guidant Corporation, Boston
cientific Ltd., Hoffmann-La Roche Ltd., Johnson & Johnson Inc.-Cordis, and the
rovince-Wide Services Committee of Alberta Health and Wellness.c
Manuscript received December 31, 2005; revised manuscript received February 16,
006, accepted February 21, 2006.hysicians feel more comfortable recommending surgery to
hese patients rather than PCI because of perceived risks,
resumably related to plaque rupture in the diseased left
ain coronary artery, a possible higher risk of proximal
isease progression, or an increased risk of guide catheter-
nduced left main complications with PCI.
Recognizing these therapeutic considerations and the
elative paucity of data on nonsignificant LMCAD, we
onducted a study of patients undergoing PCI to determine
he association between nonsignificant LMCAD and both
hort- and long-term survival. This outcome analysis is
omplemented by a secondary analysis in which we assessed
utcomes associated with nonsignificant LMCAD in a
roader collective of patients undergoing cardiac catheter-
zation, regardless of revascularization treatment received.
ETHODS
he APPROACH (Alberta Provincial Project for Out-
omes Assessment in Coronary Heart Disease) database was
tilized to identify a suitable patient cohort; APPROACH
s a clinical data collection initiative and prospective out-
ome cohort database with longitudinal follow-up that has
aptured all patients undergoing catheterization and re-
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etailed clinical information including cardiac risks, cardiac
istory, co-morbidities, and previous revascularization;
PPROACH is linked semiannually to data from the
lberta Bureau of Vital Statistics to generate survival data
n patients in the cohort.
atient selection. Over 40,000 residents of Alberta, Can-
da, had a diagnostic coronary angiogram from January
996 through December 2001. Patients with previous
ABG were excluded. Of the remaining 37,188 patients,
e excluded 2,602 who had significant (50%) LMCAD.
hereafter, the remaining 34,586 were divided into 2
ubgroups: 30,418 had no documented LMCAD and 4,168
12.1%) had nonsignificant LMCAD. In our primary anal-
sis, we excluded all patients from both groups who were
ubsequently referred for surgery, and those who were
anaged medically after the index catheterization. This
ielded a study cohort of 11,855 patients undergoing single-
essel or multivessel PCI, within which 1,385 individuals
11.7%) had documented nonsignificant (50%) LMCAD.
omparisons were made between these 2 subgroups. In a
econdary analysis done to avoid the potential selection bias
ssociated with focusing only on PCI patients, we included
ll of the 34,586 patients undergoing cardiac catheterization
nd adjusted the outcomes in the LMCAD and no
MCAD groups (see analysis section in the following text)
or both clinical variables and treatment.
tatistical methods. We used chi-square tests to compare
he baseline clinical characteristics between subgroups.
rude repeat catheterization rates 1 year after PCI are
eported to see whether differences in in-stent restenosis
ates influenced survival. Both 30-day and 1-year mortality
s well as long-term (7-year) survival were assessed by
roducing crude Kaplan-Meier curves. We then used a Cox
roportional hazards analysis (after confirming the appro-
riateness of the proportional hazards assumption) to de-
ermine risk-adjusted survival after PCI, controlling for age,
ender, left ventricular function, multivessel disease, and all
o-morbidities contained in the APPROACH database as
hown in Table 1. Risk-adjusted survival curves were
enerated using the corrected group prognosis method (5).
hese same analyses were replicated in our secondary
nalysis of all patients undergoing cardiac catheterization.
ll analyses were conducted using SAS version 8.1 (SAS
Abbreviations and Acronyms
APPROACH  Alberta Provincial Project for Outcomes
Assessment in Coronary Heart Disease
CABG  coronary artery bypass grafting
CI  confidence interval
HR  hazard ratio
IVUS  intravascular ultrasound
LMCAD  left main coronary artery disease
PCI  percutaneous coronary interventionnstitute, Cary, North Carolina). 0ESULTS
aseline characteristics are shown in Table 1. The PCI
atients with nonsignificant LMCAD were more often
en. They also had more co-morbidities such as diabetes,
enal disease, congestive heart failure, a prior history of
CI, and previous smoking. They were, however, less
ikely to be current smokers at the time of the index
atheterization.
Outcomes at 30 days and 1 year are shown in Table 2.
here were similar re-catheterization rates in the 2 groups
p  0.58) suggesting that any potential differences in
utcomes were not due to different in-stent restenosis rates
etween the 2 groups. There was no difference in mortality
t 30 days, but we observed an increased crude mortality at
year in patients with nonsignificant LMCAD.
Crude and adjusted survival curves are depicted in Figures 1
nd 2, respectively. We observed an 18% relative excess
ortality at 7 years in patients with nonsignificant LMCAD
crude hazard ratio [HR] 1.18 [95% confidence interval (CI)
.94 to 1.46]) that was not statistically significant. After
isk-adjustment for all the variables contained in the
PPROACH database, however, the curves became almost
uperimposed, and the relative risk dropped to 0.98 (95% CI
able 1. Characteristics of PCI Patients With No LMCAD
ompared With Those With 50% LMCAD
Variables (%)
No LMCAD
(n  10,470)
<50% LMCAD
(n  1,385)
p
Value
ge in yrs (SD) 61.1 (11.5) 64.0 (11.2) 0.12
ale gender 73.7 77.7 0.001
erebrovascular disease 4.6 5.6 0.09
ongestive heart failure 9.6 11.3 0.05
OPD 8.6 9.8 0.15
enal disease 1.8 2.7 0.02
iabetes mellitus 17.0 19.4 0.03
ialysis 1.0 1.0 0.83
yperlipidemia 54.1 53.5 0.68
ypertension 49.3 50.1 0.59
ndication 0.04
Stable angina 20.0 19.8
MI 47.5 49.5
Unstable angina 26.6 23.7
Other 5.8 7.1
iver/GI disease 3.2 4.1 0.06
alignancy 3.5 3.5 0.95
urrent smoker 32.6 28.5 0.002
rior MI 58.3 61.0 0.06
rior PCI 91.3 89.3 0.02
revious smoker 44.3 47.6 0.02
eripheral vascular disease 5.1 5.5 0.56
jection fraction 0.006
50% 61.6 66.4
35%–50% 22.4 19.1
20%–34% 3.7 4.0
20% 0.3 0.6
Unknown 11.9 9.9
OPD  chronic obstructive pulmonary disease; GI  gastrointestinal; LM  left
ain coronary artery; LMCAD left main coronary artery disease; MImyocardial
nfarction; PCI  percutaneous coronary intervention..79 to 1.23).
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Prognostic Importance of Nonsignificant LMCAD July 18, 2006:276–80Our secondary analysis of all patients undergoing cardiac
atheterization revealed similar trends. The crude mortality
ates for the expanded cohort of patients with nonsignificant
MCAD, regardless of treatment received (n  34,586),
re shown in Table 3. Patients with nonsignificant
MCAD had a crude mortality HR of 1.38 (95% CI 1.26
o 1.51) compared with those without LMCAD. When
djusted for clinical variables, the HR dropped to 1.03 (95%
I 0.94 to 1.14). After adjustment for both clinical variables
nd subsequent treatment received (i.e., PCI, CABG, or
edical therapy alone), the adjusted HR was 1.04 (95% CI
.95 to 1.14).
ISCUSSION
ur findings reveal an 18% excess mortality over 7 years in
CI patients with nonsignificant LMCAD compared with
atients with no documented LMCAD. Risk-adjustment
esulted in a hazard ratio of 0.98 indicating that it may not
e the nonsignificant LMCAD per se that confers the
igher risk, but rather the associated co-morbidities. This
tatement is also supported by the fact that our patients with
ocumented nonsignificant LMCAD were generally sicker
i.e., they had more co-morbidities than patients without
able 2. Outcomes at 30 Days and 1 Year in PCI Patients
ith or Without Nonsignificant LMCAD
Outcomes
No LMCAD
(n  10,470)
<50% LMCAD
(n  1,385)
p
Value
e-catheterization at 1 yr % (n) 15.1 (1,578) 14.5 (201) 0.58
eath at 30 days % (n) 1.6 (172) 2.2 (30) 0.2
eath at 1 yr % (n) 3.4 (354) 4.4 (61) 0.05
bbreviations as in Table 1.igure 1. Seven-year crude survival of percutaneous coronary intervention patient
oronary intervention patients with “nonsignificant” (i.e., 50%) LMCAD. ThMCAD). The secondary analysis of all patients undergo-
ng cardiac catheterization showed similar results for the full
ohort, suggesting that a selection bias associated with
ndergoing PCI did not influence the results of our primary
nalysis.
There is a paucity of data on so-called “nonsignificant”
MCAD. Our study is the largest published series of
atients with nonsignificant LMCAD that we could find in
he literature. However, there are some smaller studies
vailable for significant but not critical LMCAD. Conley et
l. (6) identified a relatively low-risk subgroup of 53 patients
ith significant (50% to 70%) left main stenosis and 3-vessel
oronary artery disease who had a similar 3-year survival to
he 479 patients with 3-vessel disease and normal left main
oronary artery. Using nuclear stress tests, Amanullah et al.
7) were also able to identify a subgroup of patients with
ignificant left main disease who have a low subsequent
ardiovascular event rate (7).
More recent studies have used intravascular ultrasound
IVUS) to assess subclinical left main disease. This imaging
odality may be able to detect atherosclerotic plaques that
ay remain invisible on an angiogram. The inherent limi-
ation of the visual assessment of coronary angiograms also
onstitutes one of the potential limitations of our study. As
he left main coronary artery is generally short and its
iameter varies considerably between 5 to 10 mm (8), it may
e especially difficult to properly assess the presence or
bsence of a nonobstructive plaque. In a study by Hermiller
t al. (9), 24 of 27 patients with angiographically normal left
ain coronary artery had a detectable plaque by IVUS. One
tudy published data on 107 patients undergoing PCI with
ngiographically normal or mild left main disease who hads with no left main coronary artery disease (LMCAD) versus percutaneous
in line  no LMCAD; thick line  LMCAD 50%.
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July 18, 2006:276–80 Prognostic Importance of Nonsignificant LMCADimultaneous IVUS imaging (10). Whereas the severity of
eft main coronary artery area stenosis on qualitative coro-
ary angiography was 18.2  9.8%, it was 30.2  14.7% on
VUS. During a median follow-up of 29 months (range 8 to
2 months), there were few events documented, but in a
ultivariate analysis diabetes mellitus and the minimum
uminal area on IVUS appeared to correlate with a worse
rognosis. Nevertheless, the authors allowed for the possi-
ility that more LMCAD may simply reflect more wide-
pread underlying vascular pathology. In an even smaller but
ery similar study, 30 patients underwent both single-vessel
oronary interventions and an IVUS of the left main
oronary artery (11). Twenty-one patients appeared to have
ormal left main coronary artery by angiography, but all
howed some plaque on IVUS. Eight of the 9 patients who
igure 2. Seven-year risk-adjusted survival of percutaneous coronary inte
ercutaneous coronary intervention patients with 50% LMCAD. Solid
able 3. Crude Outcomes of the Total Cohort, by Subsequent
reatment
No
LMCAD
Nonsignificant
LMCAD p Value
verall n  30,418 n  4,168
Death at 30 days (%) 1.5 2.5 0.0001
Death at 1 yr (%) 4.0 6.2 0.0001
edical therapy n  15,419 n  1,567
Death at 30 days (%) 1.3 3.1 0.0001
Death at 1 yr (%) 4.4 9.4 0.0001
ABG n  4,529 n  1,216
Death at 30 days (%) 1.4 2.1 0.11
Death at 1 yr (%) 4.1 4.3 0.82p
ABG  coronary artery bypass grafting; LMCAD  left main coronary artery
isease.ad a cardiovascular event during the 38-month (range 27
o 47 months) follow-up had a left main coronary artery area
tenosis 20%. Johnston et al. (12) proposed that centers
hould more frequently perform IVUS in concert with the
ngiographic assessment of the left main so these measure-
ents could then be correlated to long-term clinical out-
omes to better establish the natural history of LMCAD
nd the threshold for intervention.
In our study, only 11.7% of patients had documented
onsignificant LMCAD. The findings of the above-
entioned IVUS studies, however, would imply that we
lmost certainly missed some cases with left main coronary
rtery stenosis. Thus, the possibility that we compared a
roup of patients with angiographically silent but potentially
xisting nonsignificant LMCAD with patients with angio-
raphically visible nonsignificant LMCAD has to be con-
idered. However, the observed crude mortality of 12% to
4% over 7 years does not suggest that 2 high-risk groups
ere compared with each other. It appears that the more
evere left main plaque burden detected by IVUS reflects
ore severe underlying vascular pathology that is related to
higher incidence of risk factors and co-morbidities. This is
upported by our finding that more LMCAD may lead to
n increased mortality through co-morbidities rather than
he LMCAD itself.
Our findings are important because they suggest that the
ode of revascularization or the decision to proceed with
evascularization should not necessarily be influenced by the
on patients with no left main coronary artery (LMCAD) disease versus
LMCAD 50%; dashed line  no LMCAD.resence of “nonsignificant” LMCAD in and of itself.
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Prognostic Importance of Nonsignificant LMCAD July 18, 2006:276–80espite the evidence that patients with 50% left main
oronary artery stenosis have an increased cardiovascular
ortality, our findings suggest that adverse prognosis asso-
iated with LMCAD is less of a concern when the extent of
MCAD is modest and causing less than 50% stenosis.
To summarize, our study reveals an increased relative risk of
ortality in patients with nonsignificant (50%) LMCAD
hat appears to be related to these patients’ higher prevalence of
o-morbidities rather than the left main coronary artery steno-
is itself. These findings suggest that the presence of nonsig-
ificant LMCAD should not be considered as a major factor in
ecisions regarding the need for, and the mode of, revascular-
zation.
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